Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flasshove

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Gene therapy--the challenge for the futureM A Moore, J P Leonard, M Flasshove, et al.
Onkologie|February 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II studyK Höffken, F Overkamp, J Stirbu, et al.
Blood|January 15, 1995
Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transferM Flasshove, D Banerjee, S Mineishi, et al.
Cytotherapy|June 5, 2002
Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragmentsT Trarbach, S Greifenberg, W Bardenheuer, et al.
Leukemia|May 1, 1994
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinosideM Flasshove, D Strumberg, L Ayscue, et al.
Leukemia|December 1, 1996
Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitroJ K Schröder, C Kirch, M Flasshove, et al.
Acta Haematologica|November 11, 2006
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemiaL Eisele, L Klein-Hitpass, N Chatzimanolis, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2A Lindemann, P Brossart, K Höffken, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB studyA Lindemann, P Brossart, K Höffken, et al.
Human Gene Therapy|February 11, 1998
Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNAM Flasshove, D Banerjee, J P Leonard, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Gene therapy--the challenge for the futureM A Moore, J P Leonard, M Flasshove, et al.
Onkologie|February 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II studyK Höffken, F Overkamp, J Stirbu, et al.
Blood|January 15, 1995
Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transferM Flasshove, D Banerjee, S Mineishi, et al.
Cytotherapy|June 5, 2002
Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragmentsT Trarbach, S Greifenberg, W Bardenheuer, et al.
Leukemia|May 1, 1994
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinosideM Flasshove, D Strumberg, L Ayscue, et al.
Leukemia|December 1, 1996
Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitroJ K Schröder, C Kirch, M Flasshove, et al.
Acta Haematologica|November 11, 2006
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemiaL Eisele, L Klein-Hitpass, N Chatzimanolis, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2A Lindemann, P Brossart, K Höffken, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB studyA Lindemann, P Brossart, K Höffken, et al.
Human Gene Therapy|February 11, 1998
Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNAM Flasshove, D Banerjee, J P Leonard, et al.
Pageof 4